APA (7th ed.) Citation

Taşçı, E. Ş., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atcı, M. M., Sakin, A., . . . İnal, A. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer. BMC Cancer, 24(1), 1. https://doi.org/10.1186/s12885-023-11783-5

Chicago Style (17th ed.) Citation

Taşçı, Elif Şenocak, et al. "Comparing the Efficacy of Regorafenib and 5-fluorouracil-based Rechallenge Chemotherapy in the Third-line Treatment of Metastatic Colorectal Cancer." BMC Cancer 24, no. 1 (2024): 1. https://doi.org/10.1186/s12885-023-11783-5.

MLA (9th ed.) Citation

Taşçı, Elif Şenocak, et al. "Comparing the Efficacy of Regorafenib and 5-fluorouracil-based Rechallenge Chemotherapy in the Third-line Treatment of Metastatic Colorectal Cancer." BMC Cancer, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12885-023-11783-5.